Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 50, 2021 - Issue 6
229
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Implication of Increased Serum IL-31 for Primary Biliary Cholangitis

, , , &

References

  • Bağci IS, Ruzicka T. 2018. IL-31: A new key player in dermatology and beyond. J Allergy Clin Immunol. 141(3):858–66.
  • de Liso F, Matinato C, Ronchi M, Maiavacca R. 2017. The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature. Clin Chem Lab Med. 56(1):25–31.
  • Di Salvo E, Ventura-Spagnolo E, Casciaro M, Navarra M, Gangemi S. 2018. IL-33/IL-31 axis: a potential inflammatory pathway. Mediators Inflamm. 2018:3858032.
  • Ferretti E, Corcione A, Pistoia V. 2017. The IL-31/IL-31 receptor axis: general features and role in tumor microenvironment. J Leukoc Biol. 102(3):711–17.
  • Furue M, Yamamura K, Kido-Nakahara M, Nakahara T, Fukui Y. 2018. Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis. Allergy. 73(1):29–36.
  • Gibbs BF, Patsinakidis N, Raap U. 2019. Role of the pruritic cytokine IL-31 in autoimmune skin diseases. Front Immunol. 10:1383.
  • Horejs-Hoeck J, Schwarz H, Lamprecht S, Maier E, Hainzl S, Schmittner M, Posselt G, Stoecklinger A, Hawranek T, Duschl A. 2012. Dendritic cells activated by IFN-γ/STAT1 express IL-31 receptor and release proinflammatory mediators upon IL-31 treatment. J Immunol. 188(11):5319–26.
  • Huang HT, Chen JM, Guo J, Lan Y, Wei YS. 2016. The association of interleukin-31 polymorphisms with interleukin-31 serum levels and risk of systemic lupus erythematosus. Rheumatol Int. 36(6):799–805.
  • Kim S, Kim HJ, Yang HS, Kim E, Huh IS, Yang JM. 2011. IL-31 serum protein and tissue mRNA levels in patients with atopic dermatitis. Ann Dermatol. 23(4):468–73.
  • Li B, Su H, Cao J, Zhang L. 2017. CXCL13 rather than IL-31 is a potential indicator in patients with hepatocellular carcinoma. Cytokine. 89:91–97.
  • Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. 2009. American association for study of liver diseases. 2009. Primary biliary cirrhosis. Hepatology. 50(1):291–308.
  • Lleo A, Leung PSC, Hirschfield GM, Gershwin EM. 2019. The pathogenesis of primary biliary cholangitis: a comprehensive review. Semin Liver Dis Sep. 19. doi:https://doi.org/10.1055/s-0039-1697617
  • Ming D, Yu X, Guo R, Deng Y, Li J, Lin C, Su M, Lin Z, Su Z. 2015. Elevated TGF-β1/IL-31 pathway is associated with the disease severity of hepatitis B virus-related liver cirrhosis. Viral Immunol. 28(4):209–16.
  • Neis MM, Peters B, Dreuw A, Wenzel J, Bieber T, Mauch C, Krieg T, Stanzel S, Heinrich PC, Merk HF, et al. 2006. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol. 118(4):930–37.
  • Rosine N, Etcheto A, Hendel-Chavez H, Seror R, Briot K, Molto A, Chanson P, Taoufik Y, Wendling D, Lories R, et al. 2018. Increase in Il-31 serum levels is associated with reduced structural damage in early axial spondyloarthritis. Sci Rep. 8(1):7731.
  • Rüdrich U, Gehring M, Papakonstantinou E, Illerhaus A, Engmann J, Kapp A, Hartmann K, Meyer NH, Gibbs BF, Raap U. 2018. Eosinophils are a major source of interleukin-31 in bullous pemphigoid. Acta Derm Venereol. 98(8):766–71.
  • Salas-Silva S, Simoni-Nieves A, Lopez-Ramirez J, Bucio L, Gómez-Quiroz LE, Gutiérrez-Ruiz MC, Roma MG. 2019. Cholangiocyte death in ductopenic cholestatic cholangiopathies: mechanistic basis and emerging therapeutic strategies. Life Sci. 218:324–39.
  • Scheuer P. 1967. Primary biliary cirrhosis. Proc R Soc Med. 60(12):1257–60.
  • Shah RA, Kowdley KV. 2019. Mechanisms and treatments of pruritus in primary biliary cholangitis. Semin Liver Dis. 39(2):209–20.
  • Yang Z, Liang Y, Lin F, Zhang Z, Luo W, Zhang Y, Zhong R. 2018. Implication of increased serum stromal cell-derived factor-1 for primary biliary cholangitis. Int Immunopharmacol. 56:285–90.
  • Younossi ZM, Bernstein D, Shiffman ML, Kwo P, Kim WR, Kowdley KV, Jacobson IM. 2019. Diagnosis and management of primary biliary cholangitis. Am J Gastroenterol. 114(1):48–63.
  • Yu X, Guo R, Ming D, Deng Y, Su M, Lin C, Li J, Lin Z, Su Z, Hodinka RL. 2015. The transforming growth factor β1/interleukin-31 pathway is upregulated in patients with hepatitis B virus-related acute-on-chronic liver failure and is associated with disease severity and survival. Clin Vaccine Immunol. 22:484–92.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.